DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Dexanabinol is an investigational drug.
There have been 5 clinical trials for Dexanabinol. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2001.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Carcinoma, Hepatocellular, and Brain Neoplasms. The leading clinical trial sponsors are e-Therapeutics PLC, Santosh Kesari, M.D., Ph.D., and Pharmos.
Recent Clinical Trials for Dexanabinol
|A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours||e-Therapeutics PLC||Phase 1|
|Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects||e-Therapeutics PLC||Phase 1|
|Dexanabinol in Patients With Brain Cancer||e-Therapeutics PLC||Phase 1|